Bone protective agents in children.
Where this comes from
- Record sourced from PubMed, PMID 29066521.
- Also identified by DOI 10.1136/archdischild-2016-311820.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Evaluation of bone health in childhood is important to identify children who have inadequate bone mineralisation and who may benefit from interventions to decrease their risk of osteoporosis and subsequent fracture. There are no bone protective agents that are licensed specifically for the prevention and treatment of osteoporosis in children. In this review, we discuss the mechanism of action and use of bisphosphonates and other new and established bone protective agents in children.
Medical subject headings
- Bone Density Conservation Agents
- Osteoporosis